US4268518A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of treating cystitis
Assignee: Fisons Ltd
•
Filing: 1980-05-07
•
Granted: 1981-05-19
•
Expires: 2000-05-07
Abstract
Abstract There is described a method of treatment of mammalian cystitis, which method comprises administration of a compound of the formula I, ##STR1## wherein X is a polymethylene chain containing 3 to 7 carbon atoms inclusive, which chain may be substituted by an --OH group, or a pharmaceutically acceptable salt, ester or amide thereof, to a patient having cystitis.
Inventors
- 👤 David M. Turner
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 01:48
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/35
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
86 words
A method of treatment of mammalian cystitis, which method comprises oral administration or instillation into the bladder of an effective amount of a compound of the formula I, ##STR3## wherein X is a polymethylene chain containing 3 to 7 carbon atoms inclusive, which chain may be substituted by an --OH group, or a pharmaceutically acceptable salt, alkyl C 1 to 10 ester, mono-alkyl C 1 to 10 amide, di-alkyl C 1 to 10 amide or unsubstituted amide thereof, as active ingredient, to a patient having cystitis.
Claim 2
Independent Claim
86 words
A method of treatment of mammalian cystitis, which method comprises oral administration or instillation into the bladder of an effective amount of a compound of the formula I, ##STR3## wherein X is a polymethylene chain containing 3 to 7 carbon atoms inclusive, which chain may be substituted by an --OH group, or a pharmaceutically acceptable salt, alkyl C 1 to 10 ester, mono-alkyl C 1 to 10 amide, di-alkyl C 1 to 10 amide or unsubstituted amide thereof, as active ingredient, to a patient having cystitis.
Claim 3
Dependent Claim
15 words
A method according to claim 1, wherein the active ingredient is instilled into the bladder.
Claim 4
Dependent Claim
29 words
A method according to claim 1, wherein the active ingredient is instilled into the bladder as a sterile aqueous solution containing from 0.05 to 10% w/w of active ingredient.
Claim 5
Dependent Claim
19 words
A method according to claim 3, wherein the aqueous solution contains from 0.5 to 5% w/w of active ingredient.
Claim 6
Dependent Claim
19 words
A method according to claim 3, wherein from 50 to 150 ml of solution is instilled into the bladder.
Claim 7
Dependent Claim
12 words
A method according to claim 1, wherein the cystitis is interstitial cystitis.
Claim 8
Dependent Claim
12 words
A method according to claim 6, wherein the patient is a woman.
Claim 9
Dependent Claim
18 words
A method according to claim 1, wherein the active ingredient is 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane or a pharmaceutically acceptable salt thereof.
Claim 10
Dependent Claim
16 words
A method according to claim 1, wherein the active ingredient is the disodium salt of 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane.
Claim 11
Dependent Claim
20 words
A method according to claim 1, wherein from 100 to 5,000 mg of active ingredient is administered to the patient.
References Cited (Backward Citations)
US3686412A
Cited
US3777033A
Cited
US3720690A
Cited
US3975536A
Cited
US4146634A
Cited
US4152448A
Cited
US4029761A
Cited
US4067992A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-05-18 | 1984-11-17 | 1985-05-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-05-18 | 1988-11-17 | 1989-05-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-05-18 | 1992-11-17 | 1993-05-19 | $7700.00 | Window Closed / Lapsed |